New York State Common Retirement Fund
BTAI icon

New York State Common Retirement Fund’s BioXcel Therapeutics BTAI Stock Holding History

New York State Common Retirement Fund’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$221 – 3202
2024
Q2 		$221 Sell
11
-6
-35% -$201 ﹤0.01% 3371
2024
Q1 		$770 Hold
17
– – ﹤0.01% 3231
2023
Q4 		$805 Sell
17
-2
-11% -$111 ﹤0.01% 3241
2023
Q3 		$769 Sell
19
-665
-97% -$67.2K ﹤0.01% 3261
2023
Q2 		$72.9K Buy
684
+4
+0.6% +$1.33K ﹤0.01% 3035
2023
Q1 		$203K Sell
680
-43
-6% -$18.4K ﹤0.01% 2580
2022
Q4 		$249K Sell
723
-1
-0.1% -$242 ﹤0.01% 2634
2022
Q3 		$137K Buy
724
+4
+0.6% +$929 ﹤0.01% 2908
2022
Q2 		$152K Sell
720
-2
-0.3% -$421 ﹤0.01% 2911
2022
Q1 		$241K Sell
722
-1
-0.1% -$290 ﹤0.01% 2753
2021
Q4 		$235K Buy
723
+1
+0.1% +$429 ﹤0.01% 2808
2021
Q3 		$351K Sell
722
-235
-25% -$103K ﹤0.01% 2658
2021
Q2 		$445K Sell
957
-422
-31% -$230K ﹤0.01% 2664
2021
Q1 		$953K Buy
1,379
+635
+85% +$511K ﹤0.01% 2148
2020
Q4 		$550K Buy
744
+138
+23% +$107K ﹤0.01% 2308
2020
Q3 		$421K Hold
606
– – ﹤0.01% 2288
2020
Q2 		$514K Buy
606
+212
+54% +$138K ﹤0.01% 2186
2020
Q1 		$141K Sell
394
-181
-31% -$65.1K ﹤0.01% 2628
2019
Q4 		$134K Hold
575
– – ﹤0.01% 2909
2019
Q3 		$65K Hold
575
– – ﹤0.01% 3123
2019
Q2 		$101K Buy
+575
New +$97.4K ﹤0.01% 3100

Other funds holding BTAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

New York State Common Retirement Fund's BTAI Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of BioXcel Therapeutics (BTAI) in Q3 2024, closing a stake of 11 shares — an estimated $221 sold.

New York State Common Retirement Fund first reported a position in BTAI in Q2 2019 and held it in 21 quarters. The position peaked at $953K in Q1 2021. 49 funds tracked by Wall St. Rank hold BTAI as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining BioXcel Therapeutics position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 11 BioXcel Therapeutics shares in Q3 2024, an estimated $221.
  • New York State Common Retirement Fund first reported a position in BioXcel Therapeutics in Q2 2019 and held it in 21 quarters.
  • New York State Common Retirement Fund's BioXcel Therapeutics position peaked at $953K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.